For the quarter ended March 2025, T. Rowe Price (TROW) reported revenue of $1.76 billion, up 0.8% over the same period last year. EPS came in at $2.23, compared to $2.38 in the year-ago quarter.The reported revenue represents a surprise of -0.39% over the Zacks Consensus Estimate of $1.77 billion. With the consensus EPS estimate being $2.09, the EPS surprise was +6.70%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their ...

Amneal Pharmaceuticals (AMRX) reported $695.42 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 5.5%. EPS of $0.21 for the same period compares to $0.14 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $714.78 million, representing a surprise of -2.71%. The company delivered an EPS surprise of +40.00%, with the consensus EPS estimate being $0.15.While investors scrutinize revenue and earnings changes year-over-year and how they compare ...

Core Insights - Northern Oil and Gas (NOG) reported revenue of $576.95 million for the quarter ended March 2025, reflecting an 8.4% increase year-over-year and a surprise of +3.27% over the Zacks Consensus Estimate of $558.68 million [1] - The earnings per share (EPS) for the quarter was $1.33, compared to $1.28 in the same quarter last year, resulting in an EPS surprise of +18.75% against the consensus estimate of $1.12 [1] Financial Performance - Average Daily Production of Oil was 78,675 BBL/D, exceeding the estimated 77,194.71 BBL/D [4] - Average Daily Production of Natural Gas and NGLs reached 337,706 Mcf/D, surpassing the estimate of 313,853.6 Mcf/D [4] - Total Net Production was 12,146 KBOE, above the estimated 11,760.28 KBOE [4] - Average Sales Prices for Oil were $64.92, lower than the estimated $67.63 [4] - Net Sales for Oil and Gas Sales totaled $576.95 million, compared to the average estimate of $561.55 million, marking a year-over-year increase of 8.4% [4] Stock Performance - Shares of Northern Oil and Gas have returned -3.4% over the past month, while the Zacks S&P 500 composite changed by -0.5% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - Cinemark Holdings reported $540.7 million in revenue for Q1 2025, a year-over-year decline of 6.7% and an EPS of -$0.32 compared to $0.19 a year ago, with revenue exceeding the Zacks Consensus Estimate of $519.59 million by 4.06% [1] Financial Performance - The average ticket price in the U.S. Operating Segment was $10.08, exceeding the estimated $9.87, while the International Operating Segment's average ticket price was $3.53, slightly below the estimated $3.62 [4] - Concession revenues per patron in the U.S. Operating Segment were $7.98, above the estimated $7.78, and in the International Operating Segment, it was $2.88, slightly above the estimated $2.87 [4] - U.S. Operating Segment admissions revenue was $207.60 million, compared to the average estimate of $205 million, reflecting a year-over-year decline of 10.4% [4] - International Operating Segment admissions revenue was $56.50 million, surpassing the average estimate of $51.54 million, with a year-over-year decline of 2.6% [4] - U.S. Operating Segment concession revenue was $164.40 million, exceeding the estimated $161.53 million, but down 8% year-over-year [4] - International Operating Segment concession revenue was $46 million, above the average estimate of $40.83 million, showing a year-over-year increase of 0.9% [4] - Total admissions revenue was $264.10 million, compared to the average estimate of $259.33 million, representing a year-over-year decline of 8.9% [4] - Other revenue was reported at $66.20 million, exceeding the estimated $61.03 million, with a year-over-year increase of 1.5% [4] - Total concession revenue was $210.40 million, above the estimated $205.44 million, reflecting a year-over-year decline of 6.2% [4] Stock Performance - Cinemark shares have returned +19.6% over the past month, while the Zacks S&P 500 composite has seen a -0.5% change, indicating a stronger performance relative to the broader market [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Cigna (CI) reported $65.45 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 14.3%. EPS of $6.74 for the same period compares to $6.47 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $60.8 billion, representing a surprise of +7.66%. The company delivered an EPS surprise of +5.48%, with the consensus EPS estimate being $6.39.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they ...

For the quarter ended March 2025, Chevron (CVX) reported revenue of $47.61 billion, down 2.3% over the same period last year. EPS came in at $2.18, compared to $2.93 in the year-ago quarter.The reported revenue represents a surprise of -2.15% over the Zacks Consensus Estimate of $48.66 billion. With the consensus EPS estimate being $2.15, the EPS surprise was +1.40%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their ne ...

Core Insights - Fortive Corporation reported first-quarter 2025 adjusted EPS of 85 cents, in line with estimates, with a year-over-year increase of 2.4% [1] - Revenues declined 3.3% year over year to $1.47 billion, missing estimates by 1.2%, with core revenues down 1.7% [1] - The decline in revenues was primarily due to weakness in the Precision Technologies segment, partially offset by growth in Intelligent Operating Solutions and Advanced Healthcare Solutions [1] Financial Performance - Intelligent Operating Solutions generated revenues of $671.4 million, contributing 45.5% to total revenues, up 0.9% year over year [5] - Precision Technologies reported revenues of $500.6 million, down 10.5% year over year, affected by tough comparisons and customer order delays [6] - Advanced Healthcare Solutions achieved revenues of $302.2 million, up 0.8% year over year [6] - Gross profit decreased 3.1% to $880.9 million, with an adjusted operating margin of 25.3%, an increase of 20 basis points year over year [7] Strategic Developments - Fortive announced plans to separate its Precision Technologies business into an independent company, Ralliant, expected to be completed by the end of Q2 2025 [2] - The separation aims to create two focused companies, with Fortive concentrating on IOS and AHS, while Ralliant will specialize in precision instruments [2] - Management revised 2025 guidance due to delayed recovery in Precision Technologies and global tariffs, expecting adjusted diluted EPS to be $3.80 to $4 [3][10] Outlook - For Q2 2025, core performance in Precision Technologies is expected to decline, while the "New Fortive" is anticipated to maintain steady growth [12] - Adjusted EPS for Q2 is projected to be between 85 cents and 90 cents, with the Zacks Consensus Estimate at 99 cents [12] - The company is maintaining its core growth outlook for the "New Fortive," despite potential subdued demand in certain areas [11]

Harley-Davidson, Inc. (HOG) reported first-quarter 2025 adjusted earnings of $1.07 per share, which surpassed the Zacks Consensus Estimate of 80 cents. The company had reported earnings of $1.72 per share in the year-ago quarter. The motorcycle manufacturer generated consolidated revenues (including motorcycle sales and financial services revenues) of $1.33 billion, down 23% from the prior-year quarter.Segmental HighlightsHarley-Davidson Motor Company: Total revenues from the Motorcycle and Related Products ...

Magnolia Oil & Gas Corporation (MGY) reported a first-quarter 2025 net profit of 55 cents per share, which beat the Zacks Consensus Estimate of 53 cents. The bottom line also increased from the year-ago quarter’s 49 cents. This outperformance can be attributed to a healthy increase in production volumes driven by strong well productivity in the company’s Giddings asset.The oil and gas exploration and production company’s total revenues were $350.3 million, which beat the Zacks Consensus Estimate of $342 mil ...

Group 1 - Cigna Group is set to release its Q1 earnings results on May 2, with expected earnings of $6.35 per share, a decrease from $6.47 per share in the same period last year [1] - The company anticipates quarterly revenue of $60.38 billion, up from $57.25 billion a year earlier [1] - Cigna's board declared a cash dividend of $1.51 per share of its common stock on April 23 [1] Group 2 - Cigna shares experienced a decline of 1.4%, closing at $335.18 [2] - Analysts have provided various ratings and price target adjustments for Cigna, with Truist Securities maintaining a Buy rating and raising the price target from $375 to $385 [7] - UBS maintained a Buy rating but reduced the price target from $410 to $390, while Oppenheimer cut its price target from $400 to $375, both maintaining their respective ratings [7] - Raymond James reiterated a Strong Buy rating but lowered the price target from $415 to $360, and Morgan Stanley maintained an Overweight rating with a price target reduction from $403 to $379 [7]